Microvascular effects of atrial natriuretic peptide (ANP) in man: Studies during high and low salt diet

Cardiovascular Research

Volumn 39, Issue 2, 1998, Pages 442-450

  Houben, Alfons J H M ^a   Krekels, Marielle M E ^a   Schaper, Nicolaas C ^a   Fuss Lejeune, Monique J M J ^a   Rodriguez, Sergio A ^a   De Leeuw, Peter W ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ANP; Blood flow, renal; Blood flow, skin; Conjunctiva; Human; Microvascular morphometry; Nailfold

Indexed keywords

ATRIAL NATRIURETIC FACTOR; NEUROHORMONE; RENIN;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CAPILLARY DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; HEART RATE; HORMONE BLOOD LEVEL; HUMAN; KIDNEY BLOOD FLOW; LASER DOPPLER FLOWMETRY; MALE; MICROVASCULATURE; NORMAL HUMAN; ORGAN BLOOD FLOW; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; SALT INTAKE; SKIN BLOOD FLOW; SODIUM RESTRICTION; THERMOREGULATION; VENOCONSTRICTION;

EID: 0032145214     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00072-8     Document Type: Article

References (37)

1. [1] Mizelle HL, Gaillard CA, Manning RD, Hall JE. Mechanisms of decreased cardiac output during ANP infusion in conscious anephric dogs. Am J Physiol 1992;262:R120-R125.
2. [2] Vries de PJF, Tyssen CM, Struyker-Boudier HAJ, Smits JFM. Physiological role of ANP under resting and volume expanded conditions in normotensive rats. Life Sciences 1990;47:2291-2297.
3. [3] Trippodo NC, Cole FE, Frohlich ED, MacPhee AA. Atrial natriuretic peptide decreases circulatory capacitance in areflexic rats. Circ Res 1986;59:291-296.
4. [4] Lee RW, Goldman S. Mechanism for decrease in cardiac output with atrial natriuretic peptide in dogs. Am J Physiol 1989;256:H760-H765.
5. [5] Guyton AC. Cardiac output and its regulation. Philadelphia and London: Saunders, 1963.
6. [6] Almeida FA, Suzuki M, Maack T. Atrial natriuretic factor increases hematocrit and decreases plasma volume in nephrectomized rats. Life Sciences 1986;39:1193-1199.
7. [7] Fluckiger JP, Waeber B, Mtsueda G, Delaloye B, Nussberger Brunner J. Effect of atriopeptin III on hematocrit and volemia in nephrectomized rats. Am J Physiol 1986;251:H880-H883.
8. [8] de Vries PJF. Atrial natriuretic peptides: their role in cardiovascular homeostasis. Maastricht: University of Limburg, 1990 (Thesis).
9. [9] Gaillard CA, Mizelle HL, Montani JP, Brands MW, Hildebrandt DA, Hall JE. Atrial natriuretic factor and blood pressure control: role of sodium and aldosterone. Am J Physiol 1990;259:R973-R980.
10. [10] Showalter CJ, Zimmerman RS, Schwab TR, Edwards BS, Opgenorth TJ, Burnett JC. Renal response to atrial natriuretic factor is modulated by intrarenal angiotensin II. Am J Physiol 1988;254:R453-R456.
11. [11] McMurray J, Struthers AD. Effects of angiotensin II and atrial natriuretic peptide alone and in combination on urinary water and electrolyte excretion in man. Clin Sci 1988;74:419-425.
12. [12] Mantero F, Rocco S, Pertile F, et al. Effect of alpha-human atrial natriuretic peptide in low renin essential hypertension and primary aldosteronism. Clin Exp Hypertens 1987;Ag:1505-1513.
13. [13] Valentin JP, Nafrialdi N, Ribstein J, Mimran A. Endogenous angiotensin II modulates the effect of atrial natriuretic peptide on extracellular fluid partition. Am J Physiol 1993;264:R676-R680.
14. [14] Richards AM, Rao GR, Espiner EA, Yandle T. Interaction of angiotensin converting enzyme inhibition and atrial natriuretic factor. Hypertension 1989;13:193-199.
15. [15] World medical association declaration of Helsinki. Last amendment 1996. Cardiovasc Res 1997;35:2-3.
16. [16] Intaglietta M, Tompkins WR. Microvascular measurements by video image shearing and splitting. Microvascular Res 1973;5:309-312.
17. [17] Houben AJHM, Schaper NC, de Haan CHA, et al. The effects of 7-h local hyperglycaemia on forearm macro and microcirculatory blood flow and vascular reactivity in healthy man. Diabetologia 1994;37:750-756.
18. [18] Cole BR, Giangiacomo J, Ingelfinger JR, Rooson AM. Measurement of renal function without urine collection. A critical evaluation the constant infusion technique for determination of inulin and paraaminohippurate. New Engl J Med 1972;287:1109-1114.
19. [19] Kubasik NP, Warren K, Sine HE. Evaluation of a new commercial radioassay kit for aldosterone using an iodinated tracer. Clin Biochem 1978;12:59-61.
20. [20] Brun C. A rapid method for the determination of paraaminohippuric acid in kidney function tests. J Lab Clin Chem 1951;37:955-958.
21. [21] Bergmeyer HU, Bernt E, Schmidt F, Stork W. Methods of enzymatic analysis, 2nd ed. New York and London: Verlag Chemie, Weinheim/ Academic Press Inc., 1974.
22. [22] Rosmalen FM, Tan AC, Tan HS, Benraad TJ. A sensitive radioimmuniassay of atrial natriuretic peptide in human plasma, using a tracer with an immobilized glycouril reagent. Clin Chem Acta 1987;165:331-340.
23. [23] Van der Hoorn FAJ, Boomsma F, Man in 't Veld AJ, Schalekamp MADH. Determination of catecholamines in human plasma by high-performance liquid chromatography: comparison between a new method with fluorescence detection and an established method with electrochemical detection. J Chromatogr 1989;487:17-28.
24. [24] Jansen TLTA, Smits P, Tan ACITL, Thien T. Attenuated forearm vasodilator response to atrial natruiretic factor in the elderly. Hypertension 1991;18:640-647.
25. [25] Bolli P, Muller FB, Linder L, et al. The vasodilator potency of atrial natriuretic peptide in man. Circulation 1987;75:221-228.
26. [26] Ando K, Ito Y, Ogata E, Fujita T. Vasodilating actions of calcitonin gene-related peptide in normal man: comparison with atrial natriuretic peptide. Am Heart J 1992;123:111-116.
27. [27] Nilsson GE, Tenland T, Oberg BA. Evaluation of a laser Doppler flowmeter for measurement of tissue blood flow. IEEE Trans Biomed Eng 1980;BME27:597-604.
28. [28] Faber JE, Gettes DR, Gianturco DP. Microvascular effects of atrial natriuretic factor: interaction with alpha1-and alpha2-adrenoceptors. Cire Res 1988;63:415-428.
29. [29] Henriksen O. Local nervous mechanism in regulation of blood flow in human subcutaneous tissue. Acta Physiol Scand 1976;98:385-391.
30. [30] Williamson JR, Holmberg SW, Chang K, Marvel J, Sutera SP, Needleman P. Mechanisms underlying atriopeptin-induced increases in hematocrit and vascular permeation in rats. Circ Res 1989;64:890-899.
31. [31] Tucker VL, Simanonok KE, Renkin EM. Tissue specific effects of physiological ANP infusion on blood-tissue albumin transport. Am J Physiol 1992;263:R945-R953.
32. [32] Winquist RJ, Napier MA, Vandlen RL, et al. Pharmacology and receptor binding of atrial natriuretic factor in vascular smooth muscle. Clin Exp Hypertens 1985;A7:869-884.
33. [33] Doorenbos CJ, Blauw GJ, van Brummelen P. Arterial and venous effects of atrial natriuretic peptide in the human forearm. Am J Hypertens 1991;4:333-340.
34. [34] Bussien JP, Biollaz J, Waeber B, et al. Dose-dependent effect of atrial natriuretic peptide on blood pressure, herat rate, and skin blood flow of normal volunteers. J Cardiovasc Pharmacol 1986;8:216-220.
35. [35] Fujii K, Ishimatsu T, Kuriyama H. Mechanism of vasodilation induced by alpha-human atrial natriuretic polypeptide in rabbit and guinea-pig renal arteries. J Physiol 1986;377:315-322.
36. [36] Lappe RW, Todt JA, Wendt RL. Mechanisms of action of vasoconstrictor responses to atriopeptin II in conscious SHR. Am J Physiol 1985;249:R781-R786.
37. [37] Houben AJHM, Slaaf DW, Huvers FC, de Leeuw PW, Nieuwenhuijzen Kruseman AC, Schaper NC. Diurnal variations in total forearm and skin microcirculatory blood flow in man. Scand J Clin Lab Invest 1994;54:161-168.